You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
SBC: FirstString Research, Inc Topic: NIDDKProject Summary/Abstract According to the ADA, 25.8 million children and adults have diabetes. Diabetics have an increased risk of complications such as heart disease and are prone to impaired wound healing. A major cause of morbidity and hospitalizationis diabetic foot ulceration (DFUs) that may result in infection, gangrene, amputations requiring prolonged hospitalization, costly treatments, an ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
SBC: FirstString Research, Inc Topic: 200DESCRIPTION provided by applicant According to the ADA million children and adults have diabetes Diabetics have an increased risk of complications such as heart disease and are prone to impaired wound healing A major cause of morbidity and hospitalization is diabetic foot ulceration DFUs that may result in infection gangrene amputations requiring prolonged hospitalization costly tr ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Synthetic microparticle malaria vaccine
SBC: ARTIFICIAL CELL TECHNOLOGIES INC Topic: NIAIDDESCRIPTION provided by applicant This Phase II project will develop a novel synthetic microparticle vaccine for malaria using the T BT epitopes of the circumsporozoite CS protein of Plasmodium falciparum the causative agent of human malaria There is no approved vaccine for malaria a disease that causes up to million new infections and million deaths each year in the developing wor ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A serologic assay to measure successful Lyme borreliosis antibiotic therapy
SBC: L2 DIAGNOSTICS LLC Topic: RDESCRIPTION provided by applicant Lyme disease LD caused by the Ixodes tick borne spirochete Borrelia burgdorferi Bb is the most common vector borne disease in the United States Despite public health preventive measures the annual confirmed case incidence has risen to over the vast majority of which occur in the Northeast Disseminated infection causes disease in the skin heart ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
IGF::OT::IGF SBIR Topic 314 Phase II- 3D Human Tumor Co-culture System for Accurate Prediction of Clinical Efficacy.
SBC: KIYATEC, LLC Topic: NCINot Available
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens
SBC: L2 DIAGNOSTICS LLC Topic: NIAIDDESCRIPTION provided by applicant Current testing for Lyme disease is suboptimal because it requires two assay platforms including one with subjective interpretation of results and because it has lower sensitivity in the early stage of the illness Infection with Borrelia burgdorferi the causative agent of Lyme disease is transmitted by the bite of an Ixodid tick and results in uniformly lo ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Rapid assay for RNA targeted drugs: Instrumentation Supplement
SBC: NUBAD LLC Topic: 300DESCRIPTION provided by applicant Some of the most significant therapies that treat disease target nucleic acids Drugs that target nucleic acid include cancer drugs antibiotics and antivirals Combined these classes of drugs have annual sales worldwide of $ billion Antibiotics that target nucleic acids account for $ billion of the $ billion of sales annuall for all antibiotics an ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Measurement of Beta Cell Death in Diabetes
SBC: L2 DIAGNOSTICS LLC Topic: 200DESCRIPTION provided by applicant All forms of diabetes are characterized by the death of insulin producing cells In Type diabetes T D this leads to the reliance on exogenous insulin for survival Death of cells is silent it cannot be detected in vivo until it has progressed to such an extent that metabolic function is impaired The loss of cells has only been assessed by functiona ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Vault-CCL21 Nanocapsule for Lung Cancer
SBC: PROTEIN SCIENCES CORPORATION Topic: NCIDESCRIPTION provided by applicant Lung cancer is the leading cause of cancer death in the United States and is responsible for more deaths each year than breast prostate colon hepatic renal and skin cancers combined Viewed in economic terms in the United States the value of life lost from lung cancer deaths in the year was more than $ billion which is estimated to rise to more t ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Powered Walk/Run Prosthetic Ankle
SBC: Springactive, Inc. Topic: NICHDDESCRIPTION provided by applicant In the first phase of this project it was shown that by utilizing innovative technologies it was possible to allow below the knee amputees to walk and run using a single powered prosthetic device In the second phase of this project it will be shown that the key technological advancements and optimizations will allow the a single powered device to perform wa ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health